Page 2,692«..1020..2,6912,6922,6932,694..2,7002,710..»

How Veterans Affairs is helping to lead the way on prostate cancer research – Federal News Network

Best listening experience is on Chrome, Firefox or Safari. Subscribe to Federal Drives daily audio interviews onApple PodcastsorPodcastOne.

Prostate cancer is the most common type of cancer among Americas veterans population. An estimated 500,000 veterans are living with a prostate cancer diagnosis today. So it makes sense that the Veterans Health Administration would make prostate cancer research a priority. One of the latest developments is a partnership with the Prostate Cancer Foundation. Among other things, its helped to fund research into precision oncology treatments that are tailored to each patients specific physiology. Dr. Matt Rettig is the chief oncologist at the VA of Greater Los Angeles. He joined Federal Drive with Tom Temin to talk about some of the research questions VAs trying to answer.

Dr. Matt Rettig: Prostate cancer is the most commonly diagnosed major malignancy amongst veterans. In fact, its the most common major malignancy amongst males in the general US population, with somewhere around 200,000-250,000 new cases per year. Currently, there are approximately 500,000 veterans who are alive with a diagnosis of prostate cancer, and about 16,000 to 17,000 of them who have the most advanced stage of the disease, that is called metastatic prostate cancer, meaning its spread beyond the prostate to another organ. So its a big problem. Its associated with a lot of complications, what we call morbidity, as well as unfortunately, mortality. And so its a high priority malignancy for the VA so that we can better understand it and better treat it for our veterans.

Jared Serbu: As far as we know nothing specific about the veterans population per se, other than it tends to be older. So it is the rate of prostate cancer in the veterans population general reflective of what youd see in the same age groups in the general population?

Dr. Matt Rettig: It is similar, there are some important questions that need to be addressed. One is the role of Agent Orange. So Vietnam veterans whove had boots in the ground on in Vietnam War are considered to be exposed to Agent Orange, which is a service connected disease, prostate cancer associated with Agent Orange. In addition, the VA population is over represented by certain minorities, most notably African Americans as compared to the general population. And African Americans have a higher incidence of prostate cancer. And thats true in the VA system, as well as a higher mortality rate in the general population. Its not clear that theres a major difference in mortality in the veteran population. One of the major factors that results in health disparity between African Americans and Caucasians is access to care. And that is a factor that is minimized within the VA system. And in fact, many treatments that are used for prostate cancer patients, especially advanced prostate cancer patients are more effective in African Americans than Caucasians.

Jared Serbu: Interesting. So you mentioned Agent Orange is one question, what are some of the other big research questions around prostate cancer that VA is working on specifically right now?

Dr. Matt Rettig: Yeah, so prostate cancer is a major area of focus of research. And when we think about research, we think of laboratory or bench research, and clinical research, and something in between, which is called translational research, which bridges the divide between the lab and the clinic. And all three of those types of research are ongoing at the VA. Some of the big questions that we need to answer is what is the role of certain environmental exposures? Agent Orange is a good example. In the biology, the aggressiveness of prostate cancer, does it result in a different version of prostate cancer thats more aggressive, that has different genetic findings associated with it? And thats an important question thats ongoing, and then hopefully will be answered in the near future. Along those lines, we also want to know if patients who have Agent Orange is associated prostate cancer have a different response to therapy? also an important question thats ongoing, and something thats being addressed in a number of clinical trials, including some that I am conducting. Another big question is whether or not we can use the patients genetic background, the specifics of the patients tumor, the genetics that are unique to the patients tumor, in order to select the right treatment for the right patient. So historically, using drugs for cancers, including prostate cancer, has been kind of the throw the spaghetti at the wall approach where one size fits all And clearly, thats not the ideal approach. We want drugs that are going to have a higher likelihood of working in an individual patient. And knowing the specifics of the patients tumor is really critical in order to make that happen. And we do that by performing genetic sequencing on the tumor, and are able to pair a specific genetic mutation with a specific therapy. Thats not done in all patients. That is the sequencing is done. But its not all patients that have a mutation that can be paired with a specific drug. But the number of genetic changes that can be paired with a specific drug is increasing. And hopefully, we have well have a drug for it for every specific mutation in the relatively near future.

Jared Serbu: And that that whole concept youre just talking about, I think, falls in the bucket of whats sometimes called precision oncology, right? You mentioned genetic sequencing is a big part of that. But are there other factors that you look at to help tailor that treatment to a particular individual beyond the genetic sequencing?

Dr. Matt Rettig: Yeah, so thats, thats exactly right. So precision oncology is basically using patient specific features and characteristics that allow the selection of a specific therapy, a drug that is most likely to work. Now, the genetics is really the driver of precision oncology. But there are non-genetic, what we call biomarkers, factors, that can be used to select patients for therapy, including fairly straightforward clinical factors. So, for example, we know that African Americans respond to a specific type of vaccine much better than Caucasians. And the difference is quite striking. So just by having an African ancestry, one is more likely to respond to this particular treatment. So we use clinical factors that are also whats called imaging biomarkers where we have state of the art PET scans that can tell us what the patients prostate cancer is like, does it express a specific protein that can be targeted for therapy, and those are coming online. The scans have been now FDA approved. And theres therapies that are going to be imminently approved, based upon certain imaging biomarkers and imaging characteristics. So the list goes on and on. But genetics is the main driver, but other factors are used to select the right drug for the right patient.

Jared Serbu: And how mature is this whole concept of precision oncology in the prostate cancer space? Do we have any way to quantify how much more clinically effective it is than the throw the spaghetti against the wall approach that you mentioned?

Dr. Matt Rettig: Yeah, so its still in its relatively early days. So the technology to identify the genetic mutations is fairly mature. And the VA will do that on any patient with advanced cancer. In fact, not just prostate cancer, any cancer. The proportion of patients who have a mutation that would qualify them for a precision treatment varies from cancer to cancer. So about a third of all prostate cancer patients with advanced disease. The question is, really, can we get the sequencing done on a national level, so that theres no veteran thats left behind the VA is a huge integrated healthcare system. Of course, its the largest integrated health care system in the United States, there are over 150 different VA medical centers, and that doesnt include all of the outpatient clinics. And as a consequence, there is variability in the knowledge base and the resources that an individual VA may have. So what we want to do as part of the precision oncology program is to provide care to veterans, irrespective of their geography, we have another number of programs that have been initiated to achieve that. So veteran doesnt have to be at one of the main academic VA medical centers in order to achieve precision care. And so thats a really important feature of of the precision oncology program in prostate cancer, so that we can democratize precision oncology amongst all of our veterans. This project of precision oncology in prostate cancer has been going on since 2018. It was a key strategic partnership that the VA has started between the VA and the Prostate Cancer Foundation, which is the largest philanthropic institution in the United States in the world, for that matter for prostate cancer research and the prostate cancer. foundation initially funded this with $50 million. So its an incredible gift that the VA has received. And the VA has now expanded on this so that the program can reach more and more veterans.

Jared Serbu: And I assume one of the functions of that partnership would be to help export any anything that youve learned in the VA setting to the broader health communities. That a fair assessment?

Dr. Matt Rettig: Yes, absolutely. So the VA hasnt has incredible resources in terms of data mining, a huge population of veterans. And when we put databases together, we dont want to keep it just for ourselves. We want to make it accessible to researchers in the academic community who might not be at a VA so that we can learn the most from the the data and the patients that we do have.

Jared Serbu: Last thing I wanted to get to before we run out of time here is a specific clinical trial that I know you designed and worked on, where I think youre taking some of the drug therapies, or at least one drug therapy thats common for prostate cancer and trying to see if its effective in COVID-19 patients. Im gonna let you pronounce the drug for us, but tell us what what questions youve been trying to answer through that trial.

Dr. Matt Rettig: Yeah, so this was a study that we initiated last year, towards the height of COVID. Of course, were having a resurgence, at this time, at least in in many states. And we were looking for a novel way of treating COVID with an existing FDA approved drug, drug obviously wasnt approved for COVID, but can be repurposed for the treatment of severe COVID. So we tested a prostate cancer drug thats commonly used as a hormone therapy called Degarelix. And what it does is it temporarily suppresses male hormone levels. And the rationale for this testing this type of therapy amongst COVID patients was related to the mechanism, the manner in which the virus enters human cells, the target cells, for example, on the lining of the lungs. Well, there was a study published in March of last year, a landmark study, which demonstrated that the virus uses two key proteins on the surface of cells to gain entry, its like the the door that it needs to open in order to get into cells. And these two proteins, the names dont matter, but one is called ACE2, and the other ones called TMPRSS2, are well known if youre in the field of prostate cancer, because we know that theyre tightly regulated by male hormones. So male hormones cause more of these proteins, this door that the virus uses to get into cells to be expressed or present on the surface of the cells that are targeted by COVID. So the idea is that if we can temporarily suppress male hormones, and we would lower the amount of these proteins, this doorway to entry of the virus into the into the target cell, and thereby effectively treat severe COVID. So we can conducted this study., and it turns out, we were able to do it very, very rapidly, because we were using the clinical trials infrastructure of the precision oncology program, which was already in place, but was kind of on semi hold during COVID. So the infrastructure was already there. The VA rapidly funded the study, the study was completed and of course we were waiting for the results. It was a double blind study. And as the lead investigator, Im not allowed to know what the results are until theyre completed. So this is something that were waiting for. There has been a study that was conducted with a similar drug in Brazil, which was published, which showed very, very striking reduction in the duration of hospitalization, and importantly, mortality of hospitalized patients with COVID. Thats in Brazil, its a different population. They have different resources in that country as compared to the United States. But it was an interesting merging of prostate cancer and COVID-19 knowledge into a clinical trial.

Jared Serbu: That is super interesting. Im just curious on one last thing, by reducing those number of doorways on a cell surface, is the thinking that you can reduce the spread of virus throughout the body or really primarily in critical tissues like lung tissue.

Dr. Matt Rettig: Yeah, it really depends on whether or not the receptors that these doorways are regulated by male hormones on all tissues. We do see that they are regulated by male hormones in the main site of infection, which is the lining of the lungs in the respiratory system, the nasal cavity, the oropharynx As well as other important structures such as the heart. Some of the organs, we dont know the regulation of. So some of its a little bit unknown, but the main source of the virus entering cells is the lung, and we do know that the lung uses male hormones to induce the expression of these doorways, these proteins that the virus uses.

Read more:

How Veterans Affairs is helping to lead the way on prostate cancer research - Federal News Network

Read More..

Intrusion (INTZ) falls 1.19% in Light Trading on August 20 – Equities.com

Last Price$ Last TradeChange$ Change Percent %Open$ Prev Close$ High$ low$ 52 Week High$ 52 Week Low$ Market CapPE RatioVolumeExchange

INTZ - Market Data & News

Today, Intrusion Inc Incs (NASDAQ: INTZ) stock fell $0.05, accounting for a 1.19% decrease. Intrusion opened at $4.16 before trading between $4.34 and $4.08 throughout Fridays session. The activity saw Intrusions market cap fall to $73,141,700 on 196,276 shares -below their 30-day average of 4,590,594.

NTRUSION, Inc. is a global provider of entity identification, high speed data mining, cybercrime and advanced persistent threat detection solutions. INTRUSIONs family of solutions includes Shield, a combination of plug-n-play hardware, software, global data, and real-time Artificial Intelligence (AI) services that provide organizations with the most robust cybersecurity defense possible, TraceCop for identity discovery and disclosure, and Savant for network data mining and advanced persistent threat detection. INTRUSIONs solutions help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.

Visit Intrusion Inc's profile for more information.

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Intrusion Inc and to follow the company's latest updates, you can visit the company's profile page here: Intrusion Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE:The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Read the original here:

Intrusion (INTZ) falls 1.19% in Light Trading on August 20 - Equities.com

Read More..

Investors in Griffin Mining (LON:GFM) have made a solid return of 137% over the past five years – Yahoo Eurosport UK

The last three months have been tough on Griffin Mining Limited (LON:GFM) shareholders, who have seen the share price decline a rather worrying 33%. But in stark contrast, the returns over the last half decade have impressed. In fact, the share price is 137% higher today. We think it's more important to dwell on the long term returns than the short term returns. Ultimately business performance will determine whether the stock price continues the positive long term trend.

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

View our latest analysis for Griffin Mining

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

During the last half decade, Griffin Mining became profitable. Sometimes, the start of profitability is a major inflection point that can signal fast earnings growth to come, which in turn justifies very strong share price gains.

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

earnings-per-share-growth

We know that Griffin Mining has improved its bottom line lately, but is it going to grow revenue? This free report showing analyst revenue forecasts should help you figure out if the EPS growth can be sustained.

It's good to see that Griffin Mining has rewarded shareholders with a total shareholder return of 53% in the last twelve months. Since the one-year TSR is better than the five-year TSR (the latter coming in at 19% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 2 warning signs for Griffin Mining (1 is significant!) that you should be aware of before investing here.

Story continues

But note: Griffin Mining may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on GB exchanges.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Go here to see the original:

Investors in Griffin Mining (LON:GFM) have made a solid return of 137% over the past five years - Yahoo Eurosport UK

Read More..

Did right-wing organization violate campaign law and its own tax-exempt status? – Akron Beacon Journal

South Florida Sun-Sentinel

Its more than coincidence when Republican legislatures throughout the nation all start singing the same right-wing marching songs, as in the frenzy to bar critical race theory from public schools that arent even teaching the university-level discipline.

That hysteria, an outlet for pent-up racism, has been fed not just by Fox News but also by a spider web of mostly tax-exempt political organizations in which the American Legislative Exchange Council ALEC for short is arguably the most significant.

Accurately described as a conservative corporate bill mill and as the back room where laws are born, ALEC indoctrinates like-minded state legislators at annual conferences heavily subsidized by corporate donors, and it drafts model legislation to be introduced in Tallahassee, Austin and other red state capitals.

Now its accused, apparently credibly, of helping Republican legislators win elections in violation of its tax-exempt status. Two Florida lawmakers are named in the complaint.

The stand your ground law promoting the use of deadly force was hatched in Florida but eagerly promulgated nationwide by ALEC, doubtlessly to the delight of gun manufacturers. Following the 2012 shooting death of 17-year-old Trayvon Martin in Sanford, a boycott campaign prompted Coca-Cola and several other corporations to quit ALEC, which announced it would be refocusing on business-friendly legislation rather than hot-button social issues.

But now, its back in the culture wars.

The 1619 curriculum is infecting our schools, warned an ALEC post last December hyperbolically promoting a workshop on critical race theory. Diversity training is taking over our workplaces.

ALEC has also been a fountainhead of voter suppression and anti-union laws, limitations on alternative energy the petrochemical Koch brothers were major funders and pressure to reopen the public marketplace before COVID-19 could be brought under control.

Although ALEC is effectively a powerful mega lobby, it is tax-exempt as an educational organization. As such, its not supposed to make campaign contributions.

But it does that in a big way, according to complaints recently filed with the IRS and with Florida, Ohio and 13 other states. The complaints are serious and deserve to be taken as such.

[In Ohio, the Center for Media and Democracy and Common Cause Ohio requested the Ohio Elections Commission investigate allegations against three lawmakers, including Rep. Scott Wiggam, R-Wooster. The commission will review the complaint on Oct. 7.]

The complaint to the Florida Elections Commission identified Republican state Reps. Spencer Roach and Jason Fischer, ALECs two Florida state chairs, as likely recipients of valuable software thats priced beyond what Florida law allows. Neither has reported any such contribution to their campaigns or responded to emails asking for comment. No contributions from ALEC appear in the Secretary of States election database.

Florida law sets a $1,000 limit on contributions to a legislative campaign and requires the reporting of all donations, whether in money or in kind.

According to the complaint filed by the Center for Media and Democracy, one of ALECs arch-foes, it distributed election campaign software worth between $2,376 and $5,760 to an unknown number of state legislators as a benefit of their membership. The estimate Is based on the manufacturers pricing structure to non-ALEC members.

The software, produced by Voter Gravity, a concern linked to the Republican National Committee, comes fully loaded with all campaign data and functions, according to the complaint. Data entered by ALEC members supposedly is added to the RNCs database, benefitting the national party as well as local legislators.

The complaint, citing information provided by a whistleblower, contends that the software gives ALEC members access to party affiliation, ideology, issue interest, income, education, religion, Tea Party support, voter history, precinct information and turnout score data for voters in their districts, and services that they can use to create walking lists for door-knocking, set door-knocking and phone calling goals, track supporters, and create election day strike lists to maximize the turnout of their supporters.

The software's precise and voluminousinformation about voters implies massive data mining and goes far beyond the lists maintained by Florida election supervisors.

Among other things, the complaint asks the Florida Elections Commission to issue subpoenas to identify all Florida ALEC members who may have received the free software for their 2020 campaigns and determine whether they or their staff used it on state time or in state offices, along with the identities of those who funded the program.

But its improbable that the commission could do any of that for the near future. Its presently one member short of a quorum and lacks even a chair and vice chair. Five seats are vacant, leaving only four members whose terms have long since expired. Gov. Ron DeSantis is responsible for appointing replacements from lists submitted by the Senate president, House speaker and the Democratic leaders of both houses. But he has appointed no one to the commission since taking office in January 2019.

Its insane, said Barbara Anne Stern, a Fort Lauderdale lawyer who had served since 2012 until her recent resignation.

In Washington, the Internal Revenue Serviceis under new and hopefully improved management. It has often appeared indifferent to organizations abusing their tax-exempt status. The ALEC complaint is a timely and appropriate opportunity to do better.

As for DeSantis, he was a keynote speaker at ALECs confab in Salt Lake City late last month, rousing the audience with a diatribe against masking requirements and a Faucian dystopia. Although he would seem unlikely to let the Elections Commission have a go at the ALEC complaint, one can always hope. Increasingly in Florida, hope is all thats left.

Read the original:

Did right-wing organization violate campaign law and its own tax-exempt status? - Akron Beacon Journal

Read More..

Accurate prediction of protein structures and interactions using a three-track neural network – Science Magazine

Deep learning takes on protein folding

In 1972, Anfinsen won a Nobel prize for demonstrating a connection between a protein's amino acid sequence and its three-dimensional structure. Since 1994, scientists have competed in the biannual Critical Assessment of Structure Prediction (CASP) protein-folding challenge. Deep learning methods took center stage at CASP14, with DeepMind's Alphafold2 achieving remarkable accuracy. Baek et al. explored network architectures based on the DeepMind framework. They used a three-track network to process sequence, distance, and coordinate information simultaneously and achieved accuracies approaching those of DeepMind. The method, RoseTTA fold, can solve challenging x-ray crystallography and cryoelectron microscopy modeling problems and generate accurate models of protein-protein complexes.

Science, abj8754, this issue p. 871

DeepMind presented notably accurate predictions at the recent 14th Critical Assessment of Structure Prediction (CASP14) conference. We explored network architectures that incorporate related ideas and obtained the best performance with a three-track network in which information at the one-dimensional (1D) sequence level, the 2D distance map level, and the 3D coordinate level is successively transformed and integrated. The three-track network produces structure predictions with accuracies approaching those of DeepMind in CASP14, enables the rapid solution of challenging x-ray crystallography and cryoelectron microscopy structure modeling problems, and provides insights into the functions of proteins of currently unknown structure. The network also enables rapid generation of accurate protein-protein complex models from sequence information alone, short-circuiting traditional approaches that require modeling of individual subunits followed by docking. We make the method available to the scientific community to speed biological research.

Read the original here:
Accurate prediction of protein structures and interactions using a three-track neural network - Science Magazine

Read More..

The Wonders That Live at the Very Bottom of the Sea – The New York Times

The deep sea that Scales portrays is a largely unseen realm that is continually being plundered, often by people who have little notion of what they are destroying. Between the two writers, Scales is the more graceful storyteller, but Widder has (by far) the more compelling story to tell. Indeed, Scaless conceit of traveling aboard a research vessel for a couple of weeks in the Gulf of Mexico feels a bit thin, and not just by comparison to Widders heroics. She never physically ventures into the abyss, as Widder did, and as a fellow science writer, James Nestor, did in his excellent 2014 book, Deep. (In one nape-tingling chapter, he describes traveling to a depth of 2,500 feet in a homemade, unlicensed submarine cobbled together by a New Jersey eccentric.) But for its shortcomings, The Brilliant Abyss has many virtues. Scaless great gift is for transmuting our awe at the wonders of the deep sea into a kind of quiet rage that they could soon be no more.

In one of the books most appalling chapters, she describes the sad fate of the orange roughy, a remarkably slow-growing, deep-dwelling fish. Formerly known as the slimehead, the species was rebranded in the 1970s to better appeal to consumers. Demand spiked, and a gold rush mentality ensued. Trawl nets were dragged along the seafloor, hauling up not just roughies, but also the wreckage of coral reefs millennia-old, animal-grown forests which were tossed overboard as bycatch. Predictably, the fish population quickly collapsed, and they and the ecosystems that were razed to catch them have yet to return to their former vigor.

Scales excoriates not just the killers of the orange roughy, but the entire industry. Globally, she writes, deep-sea trawlers pull in profits of just $60 million a year, and yet they receive subsidies of $152 million. If it costs so much, provides so little food, and reaps such huge ecological damage, the glaring question is, why trawl for fish in the deep at all? Scales asks. Some have begun calling for a global ban on deep-sea trawling. Scales goes a step further. Looking into the future, where the mining of rare earth metals and the dumping of carbon in the deep sea promise to become lucrative (if destructive) industries, she urges us to err on the side of preservation: no deep-sea mining, fishing, oil drilling or extraction of any kind. The deep, she argues, is too vulnerable, and too crucial to the working of the planet to blindly ransack. (Among other things, the ocean acts as an enormous carbon sequestration device, one we are determinedly, if inadvertently, breaking.)

She concludes: If industrialists and powerful states have their way, and the deep is opened up to them, then it raises the ironic and dismal prospect that the deep sea will become empty and lifeless, just as people once thought it was.

Comparisons are often made between the deep sea and the cosmos. One obvious difference between the two is that the abyss below teems with life. Another is that, unlike the stars, the twinkling lights of the deep sea are hidden from view. As soon as you stop thinking about it, the deep can so easily vanish out of mind, Scales warns. She and Widder have worked hard to bring the abyss to light. It is our duty, as clumsy land-bound dwellers of a water planet, to look, and to remember.

Robert Moor is the author of On Trails: An Exploration.

BELOW THE EDGE OF DARKNESS A Memoir of Exploring Light and Life in the Deep Sea, By Edith Widder | 353 pp. Random House. $28.

THE BRILLIANT ABYSS Exploring the Majestic Hidden Life of the Deep Ocean, and the Looming Threat That Imperils It, By Helen Scales | 288 pp. Atlantic Monthly Press. $27.

Excerpt from:
The Wonders That Live at the Very Bottom of the Sea - The New York Times

Read More..

Tamo J is ‘digging up deep-rooted issues’ in therapy – Jamaica Gleaner

Recording artiste Tamo J catapulted into the dimensions of reggae-dancehall approximately five years ago and has enjoyed local success since. But the singer-songwriter, who has commanded the attention of his audience, including his peers and critics, has opened up that before now, his mind was not as clear and he wasnt operating at his best. He has since turned to therapy and is grateful for the impact the sessions have made.

Oftentimes, when the word therapy is mentioned to a person, especially a Jamaican, the response is aggressive and defensive. The reaction is usually, Me nah guh nuh shrink. After me nuh mad. Even for a youngster while growing up, we dont see them capitalising on guidance counsellors, but there are many forms of therapy around that people can benefit from using, Tamo J shared in his recent interview with The Weekend Gleaner.

He added: I was impressed by the thought when it was suggested to me because really and truly, people dont usually focus on an artistes mental state. It is more about what we can provide and do. But if an artiste, or any person for that matter, is not in the best state of mind, he or she cant fully function. I know when my mind is clear, I can operate better.

The Change the World artiste decided to face his demons head-on. That included getting to know himself better, getting past the past, and ignoring societys labels for individuals who seek or take the route of getting professional counselling.

He said: Sometimes as human beings, [we] dont realise how important it is to talk to someone. Yes, we have our peers and family members, but I dont think their capabilities are of a professional level or the advice wont come from an unbiased place. Then there is this big stigma around mental health, and the misconception where people immediately associate mental health with mental illness.

Tamo J said that growing up in Jamaica, there have always been conflicting beliefs coming from a learnt and unlearnt place that include how we are raised and the culture. Men are not encouraged to share their emotions, especially not with each other, and he, too, has heard, A why yuh a gwaan suh? Mek yuh a gwaan like one likkle girl, more than once in different environments amongst his male peers.

Males dont learn how to express [themselves]. Instead, we are exposed to constant jeering and criticism. In our culture, we love making fun of our peers, and sometimes there are deep-rooted issues you would be surprised to learn that even the comedians we laugh with, or at, are working through their own mental-health issues, he said. People always have underlying thoughts that affect how we operate daily, without us even knowing, just subconsciously. If we figure out what is happening, then we can function much better.

Tamo Js counselling sessions which have a spiritual and meditational component havent been easy. Still, he is focused on becoming his best self. At the same time, he is a beacon in the music industry simply by sharing that writing and recording music alone is not therapy. Seeking professional guidance helps, and theres no need for the inaccurate stigma. The singer-songwriter revealed that one of the issues he had to work through was love of self.

I literally went through a process of self-discovery, learning to love and embrace myself to the fullest. It is the only way to be, the way you were meant to be. If you are constantly fighting with yourself, for some people, its their physical image. For me, it was much deeper, and that clouds your judgement, Tamo J said.

In the male-dominated music industry, it can often feel like the toughest battleground. With all of us trying to accomplish the same thing, some will start seeing their peers like competition. Now, I see everyone playing them part, and I communicate differently. I have more patience and understand timing better. Its a beautiful thing, and once you dig up what was buried, you cant unsee or unthink it, he continued.

He said that his music has evolved through therapy, helping him create more efficiently and approach his craft with an international (and intentional) mindset because he is able to express himself more freely.

Im able to tap into myself and trust myself more. When writing, an artiste will track back to things people said [up] to two years or more before, and these things can restrict you from expressing ourselves and make you want to try and put everybody elses thoughts into one song instead of trusting yourself. Now, Im taking on a new perspective and trusting myself, Tamo J said.

Tamo J first opened the doors of the music industry by stepping out of the safe space of his bedroom, where he produced his eight-track EP Eccentric, then began working with renowned producers like Mikey Bennett. His singles, Miss Jamaica and Life Too Short, earned him the respect of the industry, and he became a mainstay, writing for artistes like Kranium, Sean Paul, and Denyque. He is currently under the management of Christopher Townsend, attorney-at-law and owner of Genna Storm Productions.

According to Townsend, both emerging and established artistes can benefit from therapy, and he has seen the impact it has had on Tamo J.

Before Tamo J was added to my roster, his songs were of a certain quality high quality, nonetheless but since receiving the counselling, I find the energy is noticeably different, he shared.

The recommendation for an artiste to receive therapeutic counselling has become a regular course of action for the record label to better engage the artiste and industry professionals the label works with. Noting that Tamo Js talent and experience far exceed the local stomping ground, Townsend is comforted by the fact that when it is time for the artiste to get a major breakthrough, he is going to take music to another level because he is capable, physically and mentally, and he is bussing internationally because he has that flavour, that sound, and the look.

stephanie.lyew@gleanerjm.com

Read the original:
Tamo J is 'digging up deep-rooted issues' in therapy - Jamaica Gleaner

Read More..

How to use ‘progressive muscle relaxation’ to calms stress and ease anxiety – GLAMOUR UK

After a year and a half of living through a pandemic, its no wonder that our mental health is suffering and we're struggling to get a good nights sleep. As somebody who already suffered from bad anxiety before Coronavirus, now restrictions are unlocking and life goes back to normal a little my anxiety is worse than ever, causing me to have sleepless nights, which put simply, isn't really much fun at all.

Tossing and turning most nights with anxious thoughts ticking around in our heads is something that most of us are familiar with, but something that can aid us with sleeping more soundly and helping to keep anxiety at bay, is Progressive Muscle Relaxation also known as PMR.

Julie Leonard, a life coach who has over 30 years of experience in psychology, says that progressive muscle relaxation is a method to release stress and tension from the body. It's a deep relaxation technique that can be used to control stress, anxiety, insomnia, and in some cases chronic pain.

Julie believes that PMR is a simple but effective way to calm you down, as it means youre focusing your mind and body in the present moment which stops us ruminating or worrying about the 'what ifs'.

[PMR] is great for anyone as a preventative health, however, research shows it is extremely effective in treating anxiety, stress, and sleep issues," she adds.

It has been reported that doctors have used progressive muscle relaxation in combination with other medicinal treatments for relief from pain relating to cancer and headaches, with it also working well on high blood pressure and digestive issues.

Here's how to practice PMR, according to Julie:

Julie loves to practice PMR as part of a guided meditation, so I dont have to think about which part of my body I should relax next, she tells us, I can give all my attention to my breath and tensing and relaxing my muscles. Some ways to enhance the technique are to breathe so that you can hear the sound of your breath rhythmically, like the sound of the waves rolling in and out".

Julie recommends making an event out of this calming ritual, by setting the scene with essential oils. I burn frankincense and sweet orange that are fantastic for meditation and calming the mind".

It stimulates the relaxation response, Julie says, an innate response that is the opposite of the stress response".

Julie explains how we often tense our muscles in our jaw, shoulders and hands, which can lead to headaches, muscle pain and backaches too. When practicing PMR you focus on breathing while releasing tension in our muscles. When we are focusing on our breath and relaxing our muscles, our mind is diverted from the overthinking part of the brain where our anxious thoughts are and we are distracted from the anxiety and we instead focus on relaxing".

Blogger and writer Lisa opened up to GLAMOUR about her experience with PMR. I find it really helpful, she said, having to take time out to concentrate on each set of muscles means your mind can't wander. It's very mindful. Tensing and relaxing the muscles, in turn, dampens the physically held stress in my body. It helps me switch off at the end of the day.

Lisa was recommended PMR by a mental health nurse during a particularly bad episode of anxiety. I was sceptical at first thinking it couldnt possibly help but after trying it a time or two I found it really very helpful to ease the symptoms of anxiety both mentally and physically.

She continued: You cant think bad thoughts whilst you are actively doing it and the tensing and relaxing of the muscles is really calming physically it gives you a feeling similar to what you get after a massage".

Lisa still uses the PMR technique if her anxiety takes over and she cant sleep, Its easy for your mind to race when trying to get to sleep so doing PMR settles you down and puts you in a better position to be able to fall asleep".

If your feelings of anxiety feel overwhelming and you'd like some advice, visit mind.org.uk or speak to your GP.

Read the original post:
How to use 'progressive muscle relaxation' to calms stress and ease anxiety - GLAMOUR UK

Read More..

Review: ‘Sister Sorry’ plunges deep into a shadowy abyss of the psyche. But are its characters worth caring about? – Berkshire Eagle

Theater Review

What: Sister Sorry by Alec Wilkinson. Inspired by Alec Wilkinsons The Confession, originally published in The New Yorker. Directed by Joe Calarco

With: Jennifer Van Dyck, Christopher Sears

Who: Barrington Stage Company

Where: Boyd-Quinson Stage, 30 Union St., Pittsfield

When: Through Aug. 29. 7:30 p.m. Tuesdays through Saturdays; 3 p.m. Saturdays and Sundays

Running time: 1 hour, 9 minutes (no intermission)

Tickets: $25-$69

Reservations and information:413-236-8888,barringtonstageco.org

COVID-19 SAFETY PROTOCOL: All patrons must provide proof of vaccination or proof of a negative COVID-19 test (PCR test within 72 hours or an antigen test within 6 hours) and a form of identification.

PITTSFIELD In a recent interview with The Berkshire Eagle, director Joe Calarco said that one of the reasons he was attracted to Alec Wilkinsons new play, Sister Sorry, is its theatricality.

In Calarcos hands and with the remarkably gifted Jennifer Van Dyck in the title, there is more than enough theatricality to go around at Barrington Stage Companys Boyd-Quinson Stage, where Wilkinsons two-character theater work, as he calls it, is being given a vigorously played, brilliantly staged world premiere. The question is whether, given all its theatrical accomplishment onstage from design to performance, it is all worth it; whether, like the true-life article Wilkinson penned for The New Yorker Magazine in 1993, Sister Sorry gives us people who are worth caring about? Im not convinced that it does.

Sister Sorry is a narrative spun by a conceptual artist as she looks back from present day to a time in 1993 when she conceived the idea of creating a conceptual art work she called the Sorry Line. She set up a phone line in her loft apartment and invited people to call anonymously to apologize for or confess to any sins, wrongdoings, misdeeds,crimes they may have committed at any time in their lives. When she had enough, she played them back through a telephone installation she exhibited in a small New York gallery. Afterward, she shut the line down and then restarted it, this time giving callers the opportunity to either leave their own confessions or listen to the confessions of others or both. Needless to say, Sorry Line does not attract a sunny Disneyland crowd.

I come to feel that a third of the calls are true, a third are not, and a third are a mixture of truth and fiction, she says. Someone making a confession is attempting to turn his or her life into a moral tale. A beginning, a middle, and an end. A confession becomes a story, and stories are what give our lives purpose and meaning, correct?

She remains purposefully disengaged above it all, she says. Not superior, just not drawn into the fray, until, that is, there is that one call, the "main event, she labels it, from someone calling himself Jack Flash (played with near hyper-hysteria and intensity by Christopher Sears), who confesses to a brutal crime, a murder, that he may or may not have committed. Not only is Sister Sorry drawn into the fray, she plunges deep into a shadowy abyss in her psyche that is well beyond anything she could have imagined or dared recognize within herself.

Theirs is by no means an easy relationship, especially when Sister Sorry has good reason to believe that Jacks confession may be false.

Jennifer Van Dyck and Christopher Sears star in Barrington Stage's world premiere of "Sister Sorry."

Sister Sorrys safe haven, her territory, is her loft a sizable platform center stage on which are two desk/tables with rolling chairs, two phones. Sears Jack races around the edges of the platform rear, front, sides; eventually literally invading her space, pinning her, at one point, against one of her table/desks, her back to him as she talks to him on the phone. He would be in her face, literally, were she to turn and face him. All at once, the vast, open, exposed confines of Mikiko Suzuki MacAdams evocative set, becomes claustrophobic.

Wilkinsons play poses a range of questions, not the least of them having to do with the nature of art; the relationship between the artist and the work they created. As an artist Im entitled to use the world and its thousand-and-one things any way I care to, any trespass is permissible in pursuit of art, right? Sister Sorry asks rhetorically. But, really, on reflection, what am I an artist of?

Sister Sorry also is interested in what happens when an artist is consumed, taken over, by their creation; when a work of art becomes its own creation.

Also at issue in Sister Sorry is the responsibility we hold for the choices we make in our lives; our responsibility for choices others around us make.

Wilkinson also explores the voyeur instinct within us; that impulse that allows us to look at a horrible car accident, for example, as we drive by, even if we dont want to; that draws our interest to the seedier side of human interaction, our grudging attraction to the tabloid side of life in our culture; the tacit permission that is given that behavior.

In a performance that is as untidy as his characters calculated disheveled appearance, Sears Jack Flash is an exercise in mounting hysteria that robs Jack of a dont-look attraction.

Christopher Sears plays Jack Flash, who calls in to the Sorry Line and confesses to a murder that he may or may not have committed.

On the other hand, as played by the never-less-than-astonishing Van Dyck, there is no lack of clarity, other than her own, in Sister Sorrys obsessive pursuit of Jack; her fascination with him; her surrender to the power she has over her creation, in essence.

Right from a propulsive get-go that never lets go, Van Dycks Sister Sorry catches us with a series of astonishing confessions backstory that establish the wealth of contradictions that define Sister Sorry and which we accept at face value.

Van Dycks Sister Sorry is a supremely smart woman, clearly a loner, who walks the edge of the wild side until one day, with one phone call, she goes over the edge. Her struggle in the 30 years since has been to find her way back.

I see this now, that there is a boundary in the psyche, she says near the end of the play, the mind, the unconscious, whatever you want to call it, that you can approach, but that its not safe to cross. You can never get all the way back. Even if it looks the same, it isnt.

Read the original post:
Review: 'Sister Sorry' plunges deep into a shadowy abyss of the psyche. But are its characters worth caring about? - Berkshire Eagle

Read More..

Always on your mind – The New Indian Express

Express News Service

We recently celebrated our 75th Independence Day, but I know many of us are still struggling with our need for freedom from stress, depression and anxiety, among many other issues. We must take care of our mental health and our brain to keep our overall health in place including our immunity, skin and hair. Our body is made of trillions of cells that are dependent not just on the food we eat but also on our lifestyle, our stress and our emotional and mental fatigue that we keep on feeding the brain.

We have to take equal care of our mental health because there will be no communication in our body without the brain. All communication, be it nerve function, responses, detoxification, etc. happens through the brain as it plays the role of the centre point, the core. We cant see the brain and thus we take it for granted. Its working every second of the day doing multiple activities and thats why giving it rest, whenever required, is very important to keep its function and performance at the optimum level.

Few tips for brain health

Original post:
Always on your mind - The New Indian Express

Read More..